-transparent.png){kind=logo}
We show that the anti-human immunodeficiency virus agent, 3'-azido-3'-deoxythymidine (AZT), which suppresses infectivity and cytopathic effects of human immunodeficiency virus, also effectively inhibits Epstein-Barr virus (EBV) DNA replication. However, AZT has no effect on four other human herpesviruses: cytomegalovirus, varicella-zoster virus, and herpes simplex virus types 1 and 2. The combination of acyclovir and AZT, while it is not synergistic, has an additive effect against EBV replication. AZT may prove to be a useful drug for treatment of coinfections with human immunodeficiency virus and EBV.
Related Publications
J C Lin, and
Z X Zhang, and
M C Smith, and
K Biron, and
J S Pagano
September 1987,
Journal of virology,
J C Lin, and
Z X Zhang, and
M C Smith, and
K Biron, and
J S Pagano
October 1990,
AIDS research and human retroviruses,
J C Lin, and
Z X Zhang, and
M C Smith, and
K Biron, and
J S Pagano
October 1990,
Biochemical and biophysical research communications,
J C Lin, and
Z X Zhang, and
M C Smith, and
K Biron, and
J S Pagano
June 1993,
Antimicrobial agents and chemotherapy,
J C Lin, and
Z X Zhang, and
M C Smith, and
K Biron, and
J S Pagano
January 1987,
Lancet (London, England),
J C Lin, and
Z X Zhang, and
M C Smith, and
K Biron, and
J S Pagano
June 1989,
Antimicrobial agents and chemotherapy,
J C Lin, and
Z X Zhang, and
M C Smith, and
K Biron, and
J S Pagano
April 1992,
Antimicrobial agents and chemotherapy,
J C Lin, and
Z X Zhang, and
M C Smith, and
K Biron, and
J S Pagano
January 1991,
Journal of virology,
J C Lin, and
Z X Zhang, and
M C Smith, and
K Biron, and
J S Pagano
March 1995,
Journal of virology,
J C Lin, and
Z X Zhang, and
M C Smith, and
K Biron, and
J S Pagano
September 1995,
Antiviral research,
